Munich, Germany (UroToday.com) Dr. Stefano Fanti gave an overview on the role of PET/CT in prostate cancer. There are several PET/CT markers that are available including 18F-FDG, 18F-Fluoride, 11C-Choline, 18F-Choline, 18F-FDHT, 18F-FACBC, 68GA-PSMA, and 68GA-BOM. NCCN guidelines have incorporated 11C-Choline PET for diagnosis of biochemical failure after prostatectomy. Sodium Fluoride PET has alos been incorporated for diagnosis of bone metastasis. However, PET/CT is very expensive, and despite incorporation in guidelines, there is currently no systemic approval for reimbursement by insurances in the United States.
